- Home
- CDT vs CYN Comparison
CDT vs CYN Comparison
Compare CDT & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- CYN
- Stock Information
- Founded
- CDT 2019
- CYN 2013
- Country
- CDT United States
- CYN United States
- Employees
- CDT N/A
- CYN N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- CYN EDP Services
- Sector
- CDT Health Care
- CYN Technology
- Exchange
- CDT Nasdaq
- CYN Nasdaq
- Market Cap
- CDT 10.9M
- CYN 9.3M
- IPO Year
- CDT N/A
- CYN 2021
- Fundamental
- Price
- CDT $0.11
- CYN $6.53
- Analyst Decision
- CDT
- CYN
- Analyst Count
- CDT 0
- CYN 0
- Target Price
- CDT N/A
- CYN N/A
- AVG Volume (30 Days)
- CDT 34.8M
- CYN 1.8M
- Earning Date
- CDT 11-14-2024
- CYN 11-06-2024
- Dividend Yield
- CDT N/A
- CYN N/A
- EPS Growth
- CDT N/A
- CYN N/A
- EPS
- CDT N/A
- CYN N/A
- Revenue
- CDT N/A
- CYN $102,118.00
- Revenue This Year
- CDT N/A
- CYN $18.11
- Revenue Next Year
- CDT N/A
- CYN $418.19
- P/E Ratio
- CDT N/A
- CYN N/A
- Revenue Growth
- CDT N/A
- CYN N/A
- 52 Week Low
- CDT $0.08
- CYN $2.85
- 52 Week High
- CDT $7.83
- CYN $59.50
- Technical
- Relative Strength Index (RSI)
- CDT 52.44
- CYN 67.15
- Support Level
- CDT $0.08
- CYN $5.64
- Resistance Level
- CDT $0.10
- CYN $8.75
- Average True Range (ATR)
- CDT 0.02
- CYN 0.88
- MACD
- CDT 0.00
- CYN 0.16
- Stochastic Oscillator
- CDT 33.24
- CYN 58.43
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.